JPRN-UMIN000020128Completed未知
ithium for mild-to-moderate Alzheimer's disease: A randomized double-blind, placebo-controlled study - Lithium for mild-to-moderate Alzheimer's disease: A randomized double-blind, placebo-controlled study
Department of Psychiatry, Fujita Health University School of Medicine0 sites100 target enrollmentStarted: December 11, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Creatinine clearance < 30
Investigators
Similar Trials
Completed
Phase 2
ithium for Alzheimer's diseasAlzheimer's diseaseJPRN-jRCTs041180034Iwata Nakao46
Recruiting
Unknown
Dementia treatment with combination of hydrogen gas and reduced dose lithium.Alzheimer's dementiaJPRN-jRCT1091220303Hirohisa Ono50
Completed
Phase 3
H8A-MC-LZAZPreclinical ADJPRN-jRCT2080223287Eli Lilly Japan K.K.1,150
Recruiting
Not Applicable
Balance dysfunction and falls risk in early dementia-Magnitude of the problem, and effectiveness of balance training program.Dementia (mild to moderate)Balance dysfunctionNeurological - DementiasPhysical Medicine / Rehabilitation - PhysiotherapyInjuries and Accidents - Other injuries and accidentsACTRN12608000040369ational Ageing Research Institute (NARI)264
Active, not recruiting
Phase 1
Can a common blood pressure drug, losartan, help in Alzheimer's disease?Alzheimer's DiseaseEUCTR2012-003641-15-GBorth Bristol NHS Trust228